9342-8530 Quebec Inc DGCRF

RE: Question à Ready2Go

[ready2go1]

Here is what my gut tells me. We should see the share price make a move long before PCA3 receives FDA approval. I expect a couple upward moves during updates and when GPRO finally gives it to the FDA to approve.
      My fear until that point is that we will be acquired. That question was asked by a major shareholder during the last call and I can see it taking place at these low levels. Someone can come in and acquire the company and sell off the various markers in any # of combinations. They could even just close up shop after selling off all the markers and just collect revenue from PCA3. I am clearly a PCA3 fan so I would hold on to that marker but more than likely they would acquire the company and sell PCA3 to Gen-Probe and work with GCC and blood test.
     How close is this to happening, its hard to tell. But it is something that could take place.
I have spoken to two labs that offer the test in Europe and they are very upbeat on the future, we just need to get to that point and than we will have a nice ramp and growth every quarter. The media and the Journals don't tell the entire PCA3 story and you don't hear about how this marker has destroyed other potential threats over the past 5 years. There is nothing even close and this will be how physicians respond to prostate cancer concerns in the future. Period.